MX2016013979A - Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina. - Google Patents
Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina.Info
- Publication number
- MX2016013979A MX2016013979A MX2016013979A MX2016013979A MX2016013979A MX 2016013979 A MX2016013979 A MX 2016013979A MX 2016013979 A MX2016013979 A MX 2016013979A MX 2016013979 A MX2016013979 A MX 2016013979A MX 2016013979 A MX2016013979 A MX 2016013979A
- Authority
- MX
- Mexico
- Prior art keywords
- insulin
- derivatives
- administration routes
- analogs
- new administration
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 9
- 102000004877 Insulin Human genes 0.000 title abstract 2
- 108090001061 Insulin Proteins 0.000 title abstract 2
- 229940125396 insulin Drugs 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000004026 insulin derivative Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Una insulina, análogo de insulina o derivado de insulina para uso en el tratamiento de diabetes. El uso comprende nuevas vías de administración de análogos de insulina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14305613 | 2014-04-25 | ||
| PCT/EP2015/058775 WO2015162201A1 (en) | 2014-04-25 | 2015-04-23 | New administration routes of insulin, insulin analogs or derivatives of insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016013979A true MX2016013979A (es) | 2017-01-11 |
Family
ID=50721731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016013979A MX2016013979A (es) | 2014-04-25 | 2015-04-23 | Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170119856A1 (es) |
| EP (1) | EP3134110A1 (es) |
| JP (1) | JP2017514810A (es) |
| KR (1) | KR20160143856A (es) |
| CN (1) | CN106232137A (es) |
| AU (1) | AU2015250841A1 (es) |
| CA (1) | CA2944954A1 (es) |
| MX (1) | MX2016013979A (es) |
| RU (1) | RU2016146113A (es) |
| SG (2) | SG10201809418VA (es) |
| WO (1) | WO2015162201A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109718462B (zh) * | 2017-10-27 | 2022-04-08 | 研能科技股份有限公司 | 人体胰岛素注入的供液装置 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465468B1 (en) * | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
| US20060264886A9 (en) * | 2002-05-06 | 2006-11-23 | Pettis Ronald J | Method for altering insulin pharmacokinetics |
| AU2003287073B2 (en) * | 2002-10-11 | 2009-01-08 | Becton, Dickinson And Company | System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device |
| CN101124003A (zh) * | 2003-05-06 | 2008-02-13 | 贝克顿·迪金森公司 | 施用药物的新方法和用于该方法的装置 |
| CA2524444A1 (en) * | 2003-05-06 | 2004-11-25 | Becton, Dickinson And Company | A method for altering insulin pharmacokinetics |
| CN101951957A (zh) * | 2008-01-04 | 2011-01-19 | 百达尔公司 | 胰岛素释放作为组织的葡萄糖水平的函数的胰岛素制剂 |
| JP6119609B2 (ja) * | 2011-10-28 | 2017-04-26 | 凸版印刷株式会社 | 中空針状体の製造方法，中空針状体および中空針状体送液システム |
-
2015
- 2015-04-23 WO PCT/EP2015/058775 patent/WO2015162201A1/en not_active Ceased
- 2015-04-23 SG SG10201809418VA patent/SG10201809418VA/en unknown
- 2015-04-23 SG SG11201607936QA patent/SG11201607936QA/en unknown
- 2015-04-23 AU AU2015250841A patent/AU2015250841A1/en not_active Abandoned
- 2015-04-23 CA CA2944954A patent/CA2944954A1/en not_active Abandoned
- 2015-04-23 US US15/301,820 patent/US20170119856A1/en not_active Abandoned
- 2015-04-23 JP JP2016563106A patent/JP2017514810A/ja active Pending
- 2015-04-23 MX MX2016013979A patent/MX2016013979A/es unknown
- 2015-04-23 CN CN201580021906.4A patent/CN106232137A/zh active Pending
- 2015-04-23 EP EP15719657.7A patent/EP3134110A1/en not_active Withdrawn
- 2015-04-23 RU RU2016146113A patent/RU2016146113A/ru not_active Application Discontinuation
- 2015-04-23 KR KR1020167032561A patent/KR20160143856A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2944954A1 (en) | 2015-10-29 |
| SG11201607936QA (en) | 2016-11-29 |
| WO2015162201A1 (en) | 2015-10-29 |
| JP2017514810A (ja) | 2017-06-08 |
| RU2016146113A3 (es) | 2018-12-20 |
| KR20160143856A (ko) | 2016-12-14 |
| SG10201809418VA (en) | 2018-11-29 |
| AU2015250841A1 (en) | 2016-10-27 |
| EP3134110A1 (en) | 2017-03-01 |
| US20170119856A1 (en) | 2017-05-04 |
| CN106232137A (zh) | 2016-12-14 |
| RU2016146113A (ru) | 2018-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020014121A (es) | Agonistas parciales del receptor de insulina. | |
| TW201613633A (en) | Exendin-4 derivatives as selective glucagon receptor agonists | |
| MX2017007641A (es) | Conjugados de anticuerpo-farmaco con inhibidores de bcl-xl permeables en las celulas. | |
| MY187540A (en) | Compounds active towards bromodomains | |
| MX2020002693A (es) | Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina. | |
| MX376200B (es) | Formulacion en polvo nasal para el tratamiento de hipoglicemia. | |
| PT3110840T (pt) | A22k, desb27, b29r, des b30, na posição épsilon de análogo de insulina humana acilada de lisina 22 | |
| MX2016004325A (es) | Nuevo derivado de un analogo de insulina. | |
| EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
| IL257173A (en) | New insulin histories and their medical uses | |
| WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
| EP3263155A4 (en) | Drug solution administering device | |
| EP3156055A4 (en) | Pharmaceutical composition for preventing or treating muscular weakness-related diseases, containing butylpyridinium or derivative thereof | |
| MY197524A (en) | System of multiple bags and method for the preparation of hemocomponents | |
| PH12017500602A1 (en) | Methods for treating ocular conditions | |
| GEP20196984B (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
| MX382092B (es) | Compuestos heterocíclicos para el tratamiento de enfermedades. | |
| EP3351286A4 (en) | DEVICE FOR THE ADMINISTRATION OF A MEDICAMENT SOLUTION | |
| NZ732704A (en) | Quinoline carboxamides for use in the treatment of leukemia | |
| EP3193610A4 (en) | Selective nav1.7 inhibitors for the treatment of diabetes | |
| EP3137011A4 (en) | Endodontic treatment with long term drug delivery system | |
| PH12017501979A1 (en) | Pharmaceutical compound | |
| PH12017500084A1 (en) | Vitamin b2 and its use | |
| NZ719451A (en) | Glucagon analog for treatment of severe hypoglycemia | |
| MX2016013979A (es) | Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina. |